Nerve Transfer After Spinal Cord Injury- Multi-center
Nerve Transfers to Improve Upper Extremity Function and Quality of Life in Tetraplegic Patients
1 other identifier
observational
70
2 countries
9
Brief Summary
Current treatment strategies of acute cervical spinal cord injuries remain limited. Treatment options that provide meaningful improvements in patient quality of like and long-term functional independence will provide a significant public health impact. Specific aim: Measure the efficacy of nerve transfer surgery in the treatment of patients with complete spinal cord injuries with no hand function. Optimize the efficiency of nerve transfer surgery by evaluating patient outcomes in relation to patient selection and quality of life and functional independence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2020
Longer than P75 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2019
CompletedFirst Posted
Study publicly available on registry
July 17, 2019
CompletedStudy Start
First participant enrolled
April 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedSeptember 9, 2025
September 1, 2025
5.9 years
July 11, 2019
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Manual Motor Testing
Change from baseline testing strength of upper extremities at 48 months post-operatively
48 months
Handheld Dynamometry
Change from baseline grip strength at 48 months post-operatively
48 months
Secondary Outcomes (7)
Change in Disabilities of Arm, Shoulder and Hand (DASH) scores
48 months
Change in Spinal Cord Injury Quality of Life (SCIQOL) scores
48 months
Rates of Intra-operative and post-operative complications
48 months
Hand Function, measured by the GRASSP test
48 months
Changes in the Graded Redefined Assessment of Strength, Sensation and Prehension scores (GRASSP)
48 months
- +2 more secondary outcomes
Study Arms (1)
Surgery
Surgery/ Occupational Therapy
Interventions
Surgery based on function and injury/ Occupational therapy for 48 months post-surgery
Eligibility Criteria
Participants with a traumatic cervical spine injury with little to no use of his/her arms/hands.
You may qualify if:
- Age 18-65, inclusive
- At least 3 months of non-operative rehab therapy
- Mentally and physically willing and able to comply with evaluations
- Less than 36 months post-injury
- Stable ASIA scores with no evidence of functional improvement in motor or sensory examination for at least 3 months
- ASIA A or B determined by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- EMG/NCS verifies intact innervation (normal CMAPs) to the paralyzed target muscles below the level of injury
- Functional electrical stimulation (FES) will be performed. Subject must have clinically normal MRC grade 5/5 donor (axonal) function
- Injury Level C4-C8
You may not qualify if:
- Active infection at the operative site or systemic infection
- Any return or ongoing clinical recovery of distal motor function
- Mentally or physically compromised that will prevent them from complying with evaluations.
- Immunologically suppressed
- Currently undergoing long-term steroid therapy
- Active malignancy
- Pregnant
- Significant joint contractures and/or limitations in passive range of motion in the arm or hand, per treating surgeon's discretion
- Lack of appropriate social support and/or infrastructure to commit to scheduled follow-up visits.
- Patients who are planning on undergoing a tendon transfer during the study period or who have had a tendon transfer in the past.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Washington University School of Medicinelead
- Stanford Universitycollaborator
- University of Pennsylvaniacollaborator
- University of Michigancollaborator
- University of Calgarycollaborator
- University of Utahcollaborator
- United States Department of Defensecollaborator
- The Methodist Hospital Research Institutecollaborator
- University of Miamicollaborator
- University of Albertacollaborator
Study Sites (9)
Stanford University
Stanford, California, 94305, United States
University of Miami
Miami, Florida, 33136, United States
University of Michigan
Ann Arbor, Michigan, 48109, United States
Washington University
St Louis, Missouri, 63110, United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Houston Methodist
Houston, Texas, 77030, United States
University of Utah
Salt Lake City, Utah, 84132, United States
Alberta Health Services - Foothills Medical Center
Calgary, Alberta, T2N 2T9, Canada
University of Alberta
Edmonton, Alberta, T6G 2E1, Canada
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wilson Z Ray, MD
Washington University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2019
First Posted
July 17, 2019
Study Start
April 13, 2020
Primary Completion
March 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
September 9, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
No plan to share individual participant data. Only aggregate data will be published.